scholarly journals A Case of Recurrent Cerebral Hemorrhage Considered to be Cerebral Amyloid Angiopathy by Cerebrospinal Fluid Examination.

1992 ◽  
Vol 29 (7/8) ◽  
pp. 591-595 ◽  
Author(s):  
Tomohide Adachi ◽  
Syoutai Kobayashi ◽  
Kazuya Yamashita ◽  
Kouichi Shimote ◽  
Tokugorou Tsunematsu
2021 ◽  
Vol 2 ◽  
pp. 100010
Author(s):  
Aikaterini Theodorou ◽  
Ioanna Tsantzali ◽  
Elisabeth Kapaki ◽  
Vasilios C. Constantinides ◽  
Konstantinos Voumvourakis ◽  
...  

2001 ◽  
Vol 50 (6) ◽  
pp. 765-772 ◽  
Author(s):  
Remco Natté ◽  
Marion L. C. Maat-Schieman ◽  
Joost Haan ◽  
Marjolijn Bornebroek ◽  
Raymund A.C. Roos ◽  
...  

2015 ◽  
Vol 50 (1) ◽  
pp. 1-7 ◽  
Author(s):  
María Carmona-Iragui ◽  
Ana Fernández-Arcos ◽  
Daniel Alcolea ◽  
Fabrizio Piazza ◽  
Estrella Morenas-Rodriguez ◽  
...  

Author(s):  
Kenji Sakai ◽  
Moeko Noguchi‐Shinohara ◽  
Tokuhei Ikeda ◽  
Tsuyoshi Hamaguchi ◽  
Kenjiro Ono ◽  
...  

2021 ◽  
Vol 39 (3) ◽  
pp. 172-176
Author(s):  
Ji-Yon Kim ◽  
Sungyang Jo ◽  
Yun Jik Park ◽  
Hee Jae Jung ◽  
Yong Seo Koo ◽  
...  

Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a distinct subset of cerebral amyloid angiopathy characterized by the auto-inflammatory response to amyloid-laden small arteries of cerebral cortex and leptomeninges. Clinical features include cognitive-behavioral change, headache, focal neurologic deficits and seizure. Because anti-inflammatory treatments can rapidly relieve neurologic symptoms, early diagnosis is critical. Herein, we report a CAA-RI case with distinct laboratory findings of a decreased cerebrospinal fluid amyloid beta 1-42 level and relatively reduced florbetaben uptake in the focal inflammatory lesion during the acute phase of CAA-RI.


Sign in / Sign up

Export Citation Format

Share Document